Generic Name


Brand Names
Ethacrynate, Edecrin
FDA approval date: January 10, 1967
Classification: Loop Diuretic
Form: Injection, Tablet, Powder

What is Ethacrynate (Ethacrynic)?

Ethacryname Sodium is indicated for treatment of edema when as agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable.

Top Global Experts

There are no experts for this drug

Related Clinical Trials

Pharmacokinetics of Drugs Administered to Children Per Standard of Care

Summary: This is a prospective study of children <21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Related Latest Advances

A systematic review of the evidence supporting post-operative diuretic use following cardiopulmonary bypass in children with Congenital Heart Disease.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances